期刊文献+

乳腺癌骨转移分子机制研究进展 被引量:15

Research progress on the molecular mechanism of breast cancer bone metastasis
在线阅读 下载PDF
导出
摘要 乳腺癌是女性最常见的恶性肿瘤之一,骨为其最易发生转移的部位。一旦发生骨转移,患者预后及生活质量明显下降,然而目前仍缺乏有力证据证实的、能够应用于临床的特异性诊疗手段。因此,迫切需要从其分子机制入手,寻找新的分子靶点。文中就乳腺癌骨转移在基因、蛋白及miRNA3个层面机制的研究进展作一综述,并阐述了乳腺癌骨转移动物模型的建立方法。 Breast cancer is one of the most common malignant tumors in women. Bone is commonly affected in the context of metastatic breast cancer.Once bone metastasis happens, patient would experience poor prognosis and impaired quality of life.However, there is a lack of approaches for more sensitive and specific diagnosis and treatments for breast cancer bone metastasis.Thus, it is im-perative to find new treatment target from molecular mechanism.In this paper, we review the current research progress on the molecular mechanism from several levels including gene profile, proteins and microRNAs.We also review the establishment of animal models of breast cancer bone metastasis.With the achievements acquired in the completed or undergoing researches on breast cancer bone metasta-sis, we hope the finding of the optimal diagnostic and therapeutic targets could lead the breast cancer research into a new era.
出处 《医学研究生学报》 CAS 北大核心 2015年第4期432-436,共5页 Journal of Medical Postgraduates
基金 国家重点基础研究发展计划(973计划)(2014CB744500)
关键词 乳腺癌骨转移 分子机制 动物模型 Breast cancer bone metastases Molecular mechanism Animal models
  • 相关文献

参考文献3

二级参考文献22

  • 1罗开,于泽平,王震龙,王卫红,石群立,黎介寿.乳腺癌p53和c-erbB-2基因表达与腋淋巴结转移的相关性分析[J].医学研究生学报,2004,17(10):884-886. 被引量:3
  • 2Desantis C,Ma J,Bryan L,et al.Breast cancer statistics,2013[J].CA Cancer J Clin,2014,64(1):52-62.
  • 3Rahal OM,Simmen RC.PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation[J].Carcinogenesis,2010,31(8):1491-1500.
  • 4Lu X,Liu DP,Xu Y.The gain of function of p53 cancer mutant in promoting mammary tumorigenesis[J].Oncogene,2013,32(23):2900-2906.
  • 5Kikuchi S,Nishimura R,Osako T,et al.Definition of p53 overexpression and its association with the clinicopathological features in luminal/HER2-negative breast cancer[J].Anticancer Res,2013,33(9):3891-3897.
  • 6Kim HS,Yom CK,Kim HJ,et al.Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy[J].Breast Cancer Res Treat,2010,121(3):777-788.
  • 7Soussi T,Beroud C.Assessing TP53 status in human tumours to evaluate clinical outcome[J].Nat Rev Cancer,2001,1(3):233-240.
  • 8Linderholm BK,Lindahl T,Holmberg L,et al.The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer[J].Cancer Res,2001,61(5):2256-2260.
  • 9Kastan MB,Berkovich E.p53:a two-faced cancer gene[J].Nat Cell Biol,2007,9(5):489-491.
  • 10Patil VW,Tayade MB,Pingale SA,et al.The p53 breast cancer tissue biomarker in Indian women[J].Breast Cancer (Dove Med Press),2011,3:71-78.

共引文献15

同被引文献145

引证文献15

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部